✦ LIBER ✦

Sequential evaluation of general immune competence in cancer patients: Correlation with clinical course

✍ Scribed by Frederick R. Eilber; J. Anne Nizze; Donald L. Morton

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 413 KB
Volume: 35
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197503)35:3<660::aid-cncr2820350319>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Humoral immune responses of cancer patie

Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events

✍ Elke Jäger; Elisabeth Stockert; Zacharias Zidianakis; Yao-Tseng Chen; Julia Karb 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 165 KB 👁 1 views

Humoral immune responses against the ''Cancer-Testis'' (CT) antigen NY-ESO-1 are frequently observed in patients with NY-ESO-1 expressing tumors. This is in contrast to other known tumor antigens (TA) defined by antibody or cytotoxic T cell (CTL) reactivity, i.e., MAGE-1, MAGE-3, SSX2, Melan A, and

The frequency and clinical course of cog

The frequency and clinical course of cognitive impairment in patients with terminal cancer

✍ Jose Pereira; John Hanson; Eduardo Bruera 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## METHODS. In this retrospective study, all 348 patients admitted to the Edmonton Palliative Care Program, Grey Nuns Community General Palliative Care Unit over a period of 26 months were reviewed. The Mini-Health Centre, Cross Cancer Institute, University Mental State Examination (MMSE) was used

Doubling time of serum CA 19-9 in the cl

Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis

✍ Nishida, Koichi; Kaneko, Toshiro; Yoneda, Mitsuru; Nakagawa, Shuji; Ishikawa, Ta 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Background and Objectives: Pancreatic cancer is generally a disease with a poor prognosis, and relationship between change of serum CA 19-9 level and progression of this disease was investigated with regard to clinical pace of disease and tumor growth. Methods: CA 19-9 doubling time was examined in